Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 4 | $60,700,210 |
Sells | 108 | $17,946,290 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
29 Jan 2024 16:11 | IMVT | Immunovant Inc | GEFFNER MICHAEL | Chief Medical Officer | 26 Jan 2024 | Sale | 9,948 | 37.91 | 377,129 | D |
24 May 2024 16:15 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 22 May 2024 | Sale | 16,163 | 29.65 | 479,233 | D |
23 Feb 2024 16:11 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 22 Feb 2024 | Sale | 13,454 | 36.15 | 486,362 | D |
24 Nov 2023 14:55 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 22 Nov 2023 | Sale | 15,601 | 32.75 | 510,933 | D |
13 Jan 2023 08:13 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 11 Jan 2023 | Sale | 44,448 | 16.75 | 744,504 | D |
19 Apr 2024 17:57 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 17 Apr 2024 | Sale | 26,365 | 28.8 | 759,312 | D |
13 Jan 2023 08:19 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Dev. & Tech. Officer | 11 Jan 2023 | Sale | 60,471 | 16.79 | 1,015,308 | D |
01 Sep 2023 16:08 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 30 Aug 2023 | Sale | 50,866 | 21.97 | 1,117,526 | D |
16 Aug 2023 16:11 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 14 Aug 2023 | Sale | 91,744 | 21.34 | 1,957,817 | D |
08 Aug 2023 16:44 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 07 Aug 2023 | Sale | 101,339 | 21.73 | 2,202,096 | D |
07 Oct 2022 16:32 | IMVT | Immunovant Inc | ROIVANT SCIENCES LTD. | 10% | 06 Oct 2022 | Purchase | 416,667 | 6 | 2,500,002 | D |
04 Oct 2023 17:15 | IMVT | Immunovant Inc | ROIVANT SCIENCES LTD. | Director , 10% | 02 Oct 2023 | Purchase | 1,526,316 | 38 | 58,000,008 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)